Evidence map›Paper›PMID 38318618›Full record

ArticleRSC advances2024

Iodine-catalyzed regioselective direct sulfenylation of uracil with sulfonyl hydrazide as sulfur source under solvent free conditions.

Cong Wang, Qi-Yun Peng, Yi Wu, Yan-Ling He, Xiao-He Zheng, Hai-Bo Wang, Jia-Min Xin, Qing He, Jun Xie, Lei Tang

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cong WangSchool of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang China tlei1974@163.com 1099252587@qq.com.
Qi-Yun PengSchool of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang China tlei1974@163.com 1099252587@qq.com.ORCID https://orcid.org/0009-0002-7463-2871
Yi WuSchool of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang China tlei1974@163.com 1099252587@qq.com.
Yan-Ling HeZhejiang Hisun Pharmaceutical Co., Ltd. Taizhou Zhejiang 318000 China.
Xiao-He ZhengZhejiang Hisun Pharmaceutical Co., Ltd. Taizhou Zhejiang 318000 China.
Hai-Bo WangZhejiang Hongyuan Pharmaceutical Co., Ltd. Linhai Zhejiang 317016 China.
Jia-Min XinThe First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Formulation (R&D) Department Guiyang 550001 China.
Qing HeSchool of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang China tlei1974@163.com 1099252587@qq.com.
Jun XieSchool of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang China tlei1974@163.com 1099252587@qq.com.
Lei TangSchool of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang China tlei1974@163.com 1099252587@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A facile method was developed for the selective thioetherification of uracils using sulfonyl hydrazide as the thioetherification reagent. This method offers advantages such as avoiding the use of additives and expensive metal catalysts, and providing good to excellent yields of various uracil thioethers. Experimental studies have demonstrated that the reaction follows a free radical pathway. Notably, the reaction can be carried out without solvent.

Identifiers

PMID38318618
PMCPMC10840085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.